Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aimed to evaluate the effects of intradialyic exercise on dialytic parameters, HRQL, and depression status in hemodialysis patients. A randomized controlled trial was conducted. Sixty-four participants were recruited using stratified random sampling and allocated with a 1:1 randomization ratio to either experimental group (EG, treated in odd weekdays, n = 32) or comparison group (CG, treated in even weekdays, n = 32). The EG received a 12-week intradialytic exercise, while the CG maintained usual lifestyles. Dialytic parameters, HRQL, and depression status were collected at baseline and at 12 weeks. The results indicated that there were no differences in changes of dialytic parameters from baseline between EG and CG. However, the EG had increased HRQL and reduced depression status at 12 weeks compared with the CG. A 12-week intradialytic exercise is safe, feasible and effective in improved HRQL and reduced depression status for hemodialysis patients.
Exercise has been shown to be of fundamental importance in managing chronic diseases and improving health-related quality of life (HRQL) as well as psychological health. However, whether intradialyic exercise is safe and has positive impact on HRQL and depression status in hemodialysis patients requires further researches with diverse racial and cultural groups to clarify. This study aimed to evaluate the effects of intradialyic exercise on dialytic parameters, HRQL, and depression status in hemodialysis patients. A randomized controlled trial was conducted at a medical center in Northern Taiwan. Sixty-four participants from 112 eligible hemodialysis patients were recruited using stratified random sampling and allocated with a 1:1 randomization ratio to either experimental group (EG, treated in odd weekdays, n = 32) or comparison group (CG, treated in even weekdays, n = 32). The EG received a 12-week intradialytic exercise (supine lower-limb ergometer, 30 minutes/session, 3 sessions/week), while the CG maintained usual lifestyles. Dialytic parameters (serum chemistries, serum electrolytes, and estimated glomerular filtration rate), HRQL, and depression status were collected at baseline and at 12 weeks. The results indicated that there were no differences in changes of dialytic parameters from baseline between EG and CG. However, the EG had increased HRQL (ß = 22.6, p<.001) and reduced depression status (ß = -7.5, p = .02) at 12 weeks compared with the CG. A 12-week intradialytic exercise is safe, feasible and effective in improved HRQL and reduced depression status for hemodialysis patients.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| experimental group | Experimental | The experimental group received a 12-week intradialytic exercise (supine lower-limb ergometer, 30 minutes/session, 3 sessions/week) |
|
| control group | No Intervention | the control group maintained their usual lifestyles |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| a 12-week intradialytic exercise | Behavioral | a 12-week intradialytic exercise (supine lower-limb ergometer, 30 minutes/session, 3 sessions/week) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Dialytic parameters: red blood cell [count/ul] | red blood cell [count/ul] | Change from baseline red blood cell [count/ul] assessed by blood analysis at 12 weeks |
| Dialytic parameters: hemoglobin [g/dl] | hemoglobin [g/dl] | Change from baseline hemoglobin [g/dl] assessed by blood analysis at 12 weeks |
| Dialytic parameters: hematocrit [%] | hematocrit [%] | Change from baseline hematocrit [%] assessed by blood analysis at 12 weeks |
| Dialytic parameters: mean corpuscular volume [fl] | mean corpuscular volume [fl] | Change from baseline mean corpuscular volume [fl] assessed by blood analysis at 12 weeks |
| Dialytic parameters: albumin [g/dl] | albumin [g/dl] | Change from baseline albumin [g/dl] assessed by blood analysis at 12 weeks |
| Dialytic parameters: GPT [IU/l] | GPT [IU/l] | Change from baseline [IU/l] assessed by blood analysis at 12 weeks |
| Dialytic parameters: GOT [IU/l] | GOT [IU/l] | Change from baseline GOT [IU/l] assessed by blood analysis at 12 weeks |
| Dialytic parameters: blood urea nitrogen [BUN, mg/dl] |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Chia-Huei Lin, PhD | Tri-Service General Hospital (TSGH) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chia-Huei Lin | Taipei | Hawaii | 11105 | Taiwan |
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
A randomized, controlled trial with a two parallel-group design
Not provided
Not provided
outcome assessor was blinded to the group assignment
blood urea nitrogen [BUN, mg/dl] |
| Change from baseline blood urea nitrogen [BUN, mg/dl] assessed by blood analysis at 12 weeks |
| Dialytic parameters: creatinine [Cr, mg/dl]) | creatinine [Cr, mg/dl]) | Change from baseline creatinine [Cr, mg/dl]) assessed by blood analysis at 12 weeks |
| Dialytic parameters: sodium [Na, mEq/l] | sodium [Na, mEq/l] | Change from baseline sodium [Na, mEq/l] assessed by blood analysis at 12 weeks |
| Dialytic parameters: potassium [K, mEq/l] | potassium [K, mEq/l] | Change from baseline potassium [K, mEq/l] assessed by blood analysis at 12 weeks |
| Dialytic parameters: calcium [Ca, mg/dl] | calcium [Ca, mg/dl] | Change from baseline calcium [Ca, mg/dl] assessed by blood analysis at 12 weeks |
| Dialytic parameters: phosphate [P, mg/dl] | phosphate [P, mg/dl] | Change from baseline phosphate [P, mg/dl] assessed by blood analysis at 12 weeks |
| Dialytic parameters: IPTH [pg/ml] | IPTH [pg/ml] | Change from baseline IPTH [pg/ml] assessed by blood analysis at 12 weeks |
| Dialytic parameters: estimated GFR [ml/min1.73m2]) | estimated GFR [ml/min1.73m2]) | Change from baseline estimated GFR [ml/min1.73m2]) assessed by estimation based on serum creatinine at 12 weeks |
| health-related quality of life assessed by the scale of SF-36 | self-reported health-related quality of life | Change from baseline health-related quality of life at 12 weeks |
| depression status assessed by the scale of Beck Depression inventory | self-reported depression status | Change from baseline depression status at 12 weeks |